LENZ Therapeutics, Inc.

NasdaqGS:LENZ

Sector

🏥 Health Care

Industries

🕶 Eyewear

🧬 Biotechnology

🔬 Clinical Trials

Location

United States

Market Cap

USD 915.60 M

Share Price

USD 31.48

Avg Daily Volume

246,328

Change (1 day)

-3.23%

Change (1 year)

Change (YTD)

23.89%

LENZ Therapeutics, Inc. Current Assets for the year ending December 31, 2023: USD 188.02 M

LENZ Therapeutics, Inc. Current Assets is USD 188.02 M for the year ending December 31, 2023, a -31.72% change year over year. Current assets are assets that are expected to be converted into cash or used within one year.

LENZ Therapeutics, Inc. Current Assets for the year ending December 31, 2022 was USD 275.37 M.

Competitors

Glaukos Corporation

USD 101.46

GKOS

-2.04 -1.97%

PharmaResearch Co., Ltd.

USD 420.06

214450.KQ

+45.24 12.07%

Tarsus Pharmaceuticals, Inc.

USD 39.93

TARS

-1.22 -2.96%

Ocular Therapeutix, Inc.

USD 9.61

OCUL

-0.01 -0.10%

AbbVie Inc.

USD 187.63

ABBV

-1.65 -0.87%

Novo Nordisk A/S

USD 69.09

NOVO-B.CO

-1.99 -2.80%

Roche Holding AG

USD 342.25

RO.SW

-5.82 -1.67%

Novartis AG

USD 122.10

NOVN.SW

-1.46 -1.18%

Abbott Laboratories

USD 133.70

ABT

-0.74 -0.55%

AstraZeneca PLC

USD 138.95

AZN.L

-2.01 -1.43%

Merck & Co., Inc.

USD 80.90

MRK

-0.03 -0.04%

Thermo Fisher Scientific Inc.

USD 418.70

TMO

-10.63 -2.48%

Amgen Inc.

USD 292.95

AMGN

-5.29 -1.77%

Boston Scientific Corporation

USD 103.83

BSX

-0.49 -0.47%

Pfizer Inc.

USD 25.24

PFE

-0.14 -0.55%

Gilead Sciences, Inc.

USD 111.78

GILD

+0.03 0.03%

Sanofi

USD 96.52

SAN.PA

-1.52 -1.55%

Vertex Pharmaceuticals Incorporated

USD 459.41

VRTX

-0.21 -0.05%

Bristol-Myers Squibb Company

USD 46.49

BMY

-0.43 -0.92%

Chugai Pharmaceutical Co., Ltd.

USD 47.25

4519.T

-1.65 -3.37%

Key Data

Date	Current Assets	Property, Plant, Equipment (Net)	Total Assets	Accounts Payable